Loading...
Loading...
Also known as: Nootropil, UCB 6215, 2-Oxo-1-pyrrolidineacetamide
The original nootropic — the compound that literally inspired the word "nootropic" when Corneliu Giurgea coined the term in 1972. A racetam-class cognitive enhancer that modulates AMPA receptors.
Piracetam holds a special place in nootropic history — it is the compound that started the field. Romanian psychologist Corneliu Giurgea synthesized it in 1964 and coined "nootropic" (Greek: noos = mind, tropos = turn) to describe its unique profile: cognitive enhancement without stimulation or sedation.
Piracetam's effects are subtle compared to stimulants. Users typically notice improved verbal fluency, better word recall, and enhanced reading comprehension over 2-4 weeks of consistent use. It's not a "feel-it-immediately" compound — it works by optimizing synaptic transmission over time.
Piracetam requires relatively high doses (1600-4800mg/day) because of its molecular size and moderate BBB penetration. This is why derivatives like Phenylpiracetam (30-60x more potent by weight) and Noopept (1000x) were developed.
Piracetam increases acetylcholine utilization. Without adequate choline, this can cause headaches. Always stack with Alpha-GPC (300mg) or CDP-Choline (250mg).
Piracetam is a positive allosteric modulator of AMPA receptors, enhancing glutamatergic neurotransmission without direct agonism. It increases membrane fluidity in aged neurons, restoring receptor function. It enhances acetylcholine transmission by increasing receptor density and turnover, and improves interhemispheric transfer via corpus callosum modulation.
Typical Dose
1600-4800mg
Frequency
Daily (2-3 divided doses)
Cycle Length
Ongoing (no cycling needed)
Half-Life
~5 hours
One of the most studied nootropics. Approved pharmaceutical in many countries (Nootropil). Cochrane reviews for cognitive decline. 50+ years of clinical use.
Exceptionally safe. No serious adverse effects in decades of clinical use. Possible: headache (due to choline depletion — stack with choline), mild GI discomfort, nervousness at high doses. No tolerance, no dependence, no withdrawal.
A synthetic heptapeptide nootropic derived from ACTH that enhances BDNF expression, memory, and cognitive function with neuroprotective properties.
A synthetic anxiolytic peptide derived from tuftsin with anti-anxiety, cognitive-enhancing, and immune-modulating properties.
An extremely potent angiotensin IV analog that promotes neuronal connectivity and has shown remarkable cognitive-enhancing effects in preclinical models.